Aspivix

Epalinges, Switzerland · Founded 2015 · Privately Held (backing)

Developer of a suction cervical stabilizer designed to reduce pain and eliminate the risk of lesions and bleeding in women for gynecological purposes. Aspivix is based in Epalinges, Switzerland and was founded in 2015. Its last known valuation is $28.4 million. It has raised $20.1 million.

Last price · $/share
—
Implied valuation
$28.4M
Total raised
$20.1M
Last round
—
What is Aspivix worth?
$28.4Mlast known valuation
Free account
More of Aspivix with a free account
  • ·The complete investor list: 11 names
  • ·Watch Aspivix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Aspivix funding history

No rounds on record

No funding rounds for Aspivix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Aspivix valuation

Aspivix's last known valuation is $28.4 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Aspivix's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Aspivix, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Aspivix

What is Aspivix worth?
Aspivix's last known valuation is $28.4M.
How much has Aspivix raised?
Aspivix has raised $20.1M in total funding across its recorded rounds.